CLINICAL_TRIALS
ClinicalTrials.gov record update
Bortezomib* and Vorinostat as Maintenance Therapy After Autologous Transplant for Non-Hodgkin Lymphoma Using R-BEAM or BEAM Conditioning Transplant Regimen
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00992446
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:46.647552+00:00
- Published At
- 2017-05-10T00:00:00+00:00
- Record Updated At
- 2020-03-18
- Results Posted At
- 2017-05-10
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Adult Diffuse Large B-Cell Lymphoma", "B-Cell Non-Hodgkin Lymphoma", "Follicular Lymphoma", "Mantle Cell Lymphoma", "Non-Hodgkin Lymphoma", "T-Cell Non-Hodgkin Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-03-18"- protocolSection.identificationModule.nctId
"NCT00992446"- protocolSection.identificationModule.officialTitle
"Bortezomib* and Vorinostat as Maintenance Therapy After Autologous Transplant for Non-Hodgkin Lymphoma Using R-BEAM or BEAM Conditioning Transplant Regimen"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-05-10"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.